Trials / Unknown
UnknownNCT05440071
PoSt-market Assessment on Safety and Performance of J-sHAPed xFINE Lead
- Status
- Unknown
- Phase
- —
- Study type
- Observational
- Enrollment
- 129 (estimated)
- Sponsor
- MicroPort CRM · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The primary objective of this study is to evaluate the safety and the electrical performances of the right atrial J-shape (JX model) XFINE endovascular passive lead at 3 months post implant.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | JX- XFINE lead | Pacemaker subjects implanted with one JX - XFINE passive pacing lead |
Timeline
- Start date
- 2022-09-01
- Primary completion
- 2023-10-01
- Completion
- 2024-09-01
- First posted
- 2022-06-30
- Last updated
- 2022-06-30
Source: ClinicalTrials.gov record NCT05440071. Inclusion in this directory is not an endorsement.